These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21484266)

  • 1. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.
    Mythri RB; Venkateshappa C; Harish G; Mahadevan A; Muthane UB; Yasha TC; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2011 Aug; 36(8):1452-63. PubMed ID: 21484266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.
    Venkateshappa C; Harish G; Mythri RB; Mahadevan A; Bharath MM; Shankar SK
    Neurochem Res; 2012 Feb; 37(2):358-69. PubMed ID: 21971758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in glutathione content and associated enzyme activities in the synaptic terminals but not in the non-synaptic mitochondria from the frontal cortex of Parkinson's disease brains.
    Harish G; Mahadevan A; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2013 Jan; 38(1):186-200. PubMed ID: 23070472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease.
    Venkateshappa C; Harish G; Mahadevan A; Srinivas Bharath MM; Shankar SK
    Neurochem Res; 2012 Aug; 37(8):1601-14. PubMed ID: 22461064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
    Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of the changes in enzymatic antioxidant reserves and lipid peroxidation in chosen parts of the brain in an animal model of Parkinson disease.
    Romuk EB; Szczurek W; Oleś M; Gabrysiak A; Skowron M; Nowak P; Birkner E
    Adv Clin Exp Med; 2017 Sep; 26(6):953-959. PubMed ID: 29068596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
    Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restraint stress-induced oxidative damage and its amelioration with selenium.
    Atif F; Yousuf S; Agrawal SK
    Eur J Pharmacol; 2008 Dec; 600(1-3):59-63. PubMed ID: 18854182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione metabolism is modulated by postmortem interval, gender difference and agonal state in postmortem human brains.
    Harish G; Venkateshappa C; Mahadevan A; Pruthi N; Srinivas Bharath MM; Shankar SK
    Neurochem Int; 2011 Dec; 59(7):1029-42. PubMed ID: 21945455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson's Disease.
    Cruces-Sande A; Rodríguez-Pérez AI; Herbello-Hermelo P; Bermejo-Barrera P; Méndez-Álvarez E; Labandeira-García JL; Soto-Otero R
    Mol Neurobiol; 2019 Apr; 56(4):2845-2854. PubMed ID: 30066305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex I syndrome in striatum and frontal cortex in a rat model of Parkinson disease.
    Valdez LB; Zaobornyj T; Bandez MJ; López-Cepero JM; Boveris A; Navarro A
    Free Radic Biol Med; 2019 May; 135():274-282. PubMed ID: 30862545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
    Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
    J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.